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Introduction
The rapid recruitment of innate immune cells is critical for con-
taining and eradicating infection and the restoration of normal 
tissue homeostasis. To enable effective immune responses in 
the tissues, leukocytes are required to adapt to the physiological 
challenges provided by the inflammatory niche. This is reflected 
in the ability of neutrophils to survive and function under condi-
tions of limited oxygen availability (1–3). Hypoxia in the context 
of pneumonia is associated with poorer outcomes in patients (4, 
5) and we have previously shown that in murine models of bac-
terial pneumonia increased sickness in hypoxia is neutrophil- 
dependent (6). Furthermore, myeloid cell–specific loss of the crit-
ical oxygen-sensing prolyl hydroxylase PHD2 resulted in a dam-
aging inflammatory neutrophil phenotype in sterile and infective 
models of inflammation (7). Hypoxia is therefore an important 
determinant of neutrophil behavior.
Variations in both local and systemic tissue oxygenation may be 
amplified in disease, for example in acute respiratory distress syn-
drome (ARDS) and more recently in coronavirus 2019 (COVID-19) 
disease. In both contexts, worsening hypoxia and alveolar damage 
are associated with increased mortality (8–10). Infiltrating neutro-
phils in the setting of ARDS drive an overexuberant inflammato-
ry response that is highly damaging to host tissue (8), increasing 
vascular injury and protein leak (9, 10) and promoting the alveolar 
epithelial injury that dictates disease progression (11–13).
The release of granule proteases at the site of injury or infection 
represents a key component of the neutrophil’s antimicrobial rep-
ertoire and these proteases are known to contribute significantly to 
tissue damage in ARDS (14). To facilitate the rapid release of these 
proteins, granules and their contents are preformed and packaged 
during neutrophil maturation in the bone marrow through a tem-
porally regulated program of transcription and translation (15, 16). 
Degranulation is necessarily a highly regulated process, as inap-
propriate release of these toxic proteins risks host cell and tissue 
damage. The ability of neutrophils to sustain damaging, proinflam-
matory responses in oxygen- and nutrient-limited tissues raises 
the important possibility that neutrophils continue to synthesize 
destructive granule proteases.
Here we used a lung injury model to interrogate the processes 
that drive harmful neutrophil phenotypes. Quantitative label-free 
mass-spectrometry revealed that inflammatory neutrophils have a 
dynamic proteome that is restructured in response to the physiolog-
ical stress of hypoxia. Tracing of labeled amino acids and proteins 
identified the capacity of airway neutrophils to undergo de novo pro-
tein synthesis and activate lysosomal functions required to metab-
olize extracellular proteins to fuel this response. Consistent with 
this finding, systemic hypoxia aggravates lung injury, a response 
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neutrophils (Figure 2A). TNF-α signaling is implicated in neutrophil 
adhesion (22), priming (23), and apoptosis (24). TNF-α was detect-
ed in the BAL supernatant following LPS-induced lung injury (Sup-
plemental Figure 2A) and hypoxic airspace neutrophils displayed 
higher levels of TNFRSF1b (TNF receptor 2) protein (Figure 2B). 
Flow cytometry confirmed higher surface expression of TNFRSF1b 
on hypoxic neutrophils harvested 24 hours after LPS (Supplemen-
tal Figure 2B). TNF receptor 1 was not identified on the neutrophil 
proteome but could be measured by flow cytometry. This identified 
a distinct pattern of expression with higher levels in hypoxia at 6 
hours after LPS, but equivalent expression by 24 hours (Supplemen-
tal Figure 2C). Thus, hypoxia may regulate neutrophil response to 
TNF-α through dynamic regulation of surface receptor expression.
One of the most upregulated proteins in the hypoxic neutro-
phil proteome was the beta component of the GM-CSF receptor 
(CSF2RB, Figure 2C). Ligation of the GM-CSF receptor results 
in wide-ranging inflammatory neutrophil responses, including 
priming, degranulation (25), and survival (26). Flow cytometry 
confirmed BAL neutrophil surface expression of both the α and β 
subunit of this heterodimeric receptor. Both subunits were upreg-
ulated in hypoxia 6 hours after LPS with equivalent surface expres-
sion between groups by 24 hours (Supplemental Figure 2, D and 
E). This hypoxic induction of GM-CSF receptor surface expression 
early in the inflammatory response is associated with increased 
neutrophil degranulation in vivo at 6 hours, with significantly 
higher levels of elastase activity (Figure 2D) and MMP9 (Figure 
2E) in hypoxic BAL supernatant. Degranulation is maximal at this 
early time point with levels of both elastase and MMP9 in the BAL 
falling by 24 hours (Supplemental Figure 3, A and B).
Despite detection of free elastase and MMP9 in the airways, 
the proteomic data set showed that airspace neutrophils retain high 
protein expression of azurophilic, specific and gelatinase granule 
proteins (Figure 2F), and showed no reduction in intracellular lev-
els of the key granule proteins under conditions of hypoxia (Figure 
2, G and H, and Supplemental Figure 3, C and D) where enhanced 
degranulation is observed. Persistence of granule proteins in 
hypoxic neutrophils despite evidence of increased degranulation 
led us to hypothesize that tissue neutrophils may have the capacity 
to synthesize granule proteins upon recruitment to the inflamma-
tory niche, in contrast to the existing dogma that granule proteins 
are only synthesized and packaged in bone marrow neutrophils 
(15). Consistent with this possibility, hypoxia positively regulated 
many eukaryotic translation initiation factors (EIFs), essential for 
initiation of protein translation (Figure 2I) and aminoacylation of 
tRNAs (Figure 2, J and K). Furthermore, airspace neutrophils retain 
mRNAs for granule proteins (Supplemental Figure 3, E and F).
Airspace neutrophils synthesize granule proteins. To directly 
address the extent to which tissue neutrophils continue to synthesize 
inflammatory proteins, we measured the protein synthetic capac-
ity of inflammatory BAL neutrophils by ex vivo incubation of BAL 
neutrophils with the heavy labeled amino acids 13C6 and 
15N4 l-argi-
nine and 13C6 l-lysine. BAL neutrophils from animals that had been 
housed in hypoxia following LPS stimulation were used because we 
predicted, based on the proteomic data presented here, that these 
would have the greatest capacity for ongoing protein synthesis. Neu-
trophils were isolated 6 hours after LPS nebulization and cultured 
with heavy labeled amino acids for 18 hours to generate samples 
curtailed by lysosomal inhibition. This immune-metabolic leuko-
cyte phenotype is of likely importance in both health and disease.
Results
Inflammatory neutrophils restructure their proteome in response to 
hypoxia. We first sought to develop a comprehensive map of the pro-
teome of an inflammatory neutrophil to assess its capacity to respond 
to different environments and stimuli, something a genomics 
approach could not address. Moreover, the quantification of absolute 
protein abundance allows the unbiased analysis of the factors that 
differentiate the normoxic from the hypoxic neutrophil population.
Mice were exposed to nebulized lipopolysaccharide (LPS) 
using a sealed system to generate a uniform and reproducible lung 
injury. Airspace neutrophils were isolated from bronchoalveolar 
lavage (BAL) of mice 24 hours after induction of lung injury. Using 
high resolution mass spectrometry, we identified 57,000 peptides 
from these highly pure neutrophil preparations (Supplemental Fig-
ure 1, A and B; supplemental material available online with this 
article; https://doi.org/10.1172/JCI134073DS1), corresponding to 
more than 5000 proteins. High correlation between biological rep-
licates was observed (R2 > 0.96, Supplemental Figure 1C). Protein 
copy numbers were calculated on Perseus software (17) using the 
proteomic ruler (18) and used to analyze the contribution of pro-
teins to the total protein mass (Supplemental Figure 1D). Proteins 
were divided into quartiles by abundance (measured by label-free 
quantification [LFQ] intensity) and the top 2 quartiles were ana-
lyzed for KEGG pathway enrichment (as compared with the whole 
neutrophil proteome) using online DAVID software (19, 20). This 
analysis of the most abundant proteins highlighted that metabolic, 
migratory, inflammatory, and biosynthetic pathways dominate the 
inflammatory neutrophil proteome (Figure 1, A and B), with 7% total 
protein mass attributable to glycolysis, 6% to regulation of trans-
lation, and 5% to granule proteins (Figure 1, C–E). Enrichment of 
inflammatory, metabolic, and biosynthetic pathways was observed 
in neutrophils relative to the whole murine genome (Supplemental 
Tables 1–3). We next questioned how neutrophils restructure their 
proteome in response to the physiological challenge of hypoxia and 
low glucose availability, to which neutrophils are subjected in vivo. 
Given existing evidence that oxygen availability critically regulates 
innate immune responses to lung injury and infection (6, 7), we 
studied a model of hypoxic acute lung injury. Following nebuliza-
tion (as described above), animals were transferred to a hypoxic 
chamber where the inhaled oxygen concentration was reduced to 
10% over 1 hour. Proteomic analysis revealed a distinct protein 
signature in neutrophils from mice exposed to concurrent system-
ic hypoxia as compared with those from normoxic controls during 
acute lung injury (Figure 1F), with upregulation of 272 proteins and 
downregulation of 230 proteins (P < 0.05, FDR 0.05, S0= 0.1; Fig-
ure 1G). Hypoxic samples also showed high correlation among bio-
logical replicates (Supplemental Figure 1E).
Hypoxic neutrophils upregulate inflammatory receptors and trans-
lational machinery. Analysis of those proteins that were significant-
ly upregulated in hypoxia revealed a number of key inflammatory 
receptors. Formylated peptide receptor (FPR) signaling is implicat-
ed in the regulation of neutrophil chemotaxis, degranulation, ROS 
production, and transcriptional regulation (21). Both FPR1 and 
FPR2 were significantly upregulated in the proteome of hypoxic 
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Figure 1. Inflammatory neutrophils restructure their proteome in response to hypoxia. (A) Histogram of all identified proteins split into quartiles based 
on LFQ intensity. KEGG pathway analysis of enriched pathways in the top quartile (dark blue) and second quartile (green) are highlighted. The top 20 
proteins (by LFQ intensity) are expanded in (B). The contributions of (C) the glycolysis/gluconeogenesis KEGG pathway, (D) the Gene Ontology Biological 
Process Regulation of Translation, and (E) granule proteins to the total protein content of a neutrophil were calculated. The proteome of normoxic and 
hypoxic BAL neutrophils were analyzed for (F) principle component analysis, performed without category enrichment in components. (G) Volcano plot 
demonstrating significant up- (green) and downregulation (red) of more than 200 proteins in hypoxic samples (P < 0.05, FDR 0.05, S0 = 0.1). For all data, 
 n = 3 per condition. Panels D and E represent individual values and mean ± SEM. Panel F represents each biological replicate.
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Figure 2. Hypoxia promotes a hyperinflammatory biosynthetic neutrophil phenotype. LFQ of (A) FPRs 1 and 2, (B) TNFRSF2, and (C) GM-CSF receptor subunit β 
in BAL neutrophils from normoxic and hypoxic mice, n = 3. (D) Elastase activity (n = 11 over 3 experiments) and (E) MMP9 concentration (n = 6 over 2 experiments) 
in BAL supernatant from normoxic and hypoxic mice 6 hours after LPS, Mann-Whitney test of significance. (F) Histogram of the normoxic neutrophil proteome 
with the positions of granule proteins highlighted. LFQ of (G) elastase and (H) MMP9 in normoxic and hypoxic BAL neutrophils, n = 3. Volcano plots illustrating 
upregulation of EIFs (I) and tRNA ligases (J) with the fold change of tRNA ligases detailed in (K) with upregulated proteins highlighted in green. A–C, G, H, and K 
used unpaired 2-tailed t test of significance. In A–E, G, and H, data represent individual values and mean ± SEM. In K, data represent mean ± SEM. FPR, formylat-
ed peptide receptor; TNFRSF2, TNF receptor superfamily member 2; CSF2RB, GM-CSF receptor subunit β; SCAMP2, secretory carrier-associated membrane protein 
2; CTSD, cathepsin D; ELANE, neutrophil elastase; PRTN3, myeloblastin (proteinase 3); LYZ2, lysozyme C-2; NGP, neutrophil granule protein; MPO, myeloperoxi-
dase; LTF, lactotransferrin; EIF, eukaryotic translation initiation factor.
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this metabolite deplete environment. In contrast to intracellular 
glucose levels, hypoxic neutrophils were found to have significantly 
higher levels of intracellular glutamine and glutamate (Figure 4D). 
LCMS analysis of airway fluid did detect glutamine, but there was 
no increase in hypoxic airways (Figure 4E). Furthermore, at a pro-
tein level, neutrophils did not reproducibly express the important 
SLC-38 family of glutamine transporters (Supplemental Figure 4B) 
(30), suggesting that transport of free glutamine does not account 
for the observed increase in intracellular glutamine in hypoxia.
Survey of the neutrophil proteome led to the surprising obser-
vation that neutrophils contain the extracellular proteins albumin, 
IgM, and fibronectin, and that they increase in abundance when 
neutrophils are exposed to hypoxic lung injury (Figure 4, F–H). This 
led us to question whether neutrophils can scavenge proteins to use 
as an alternative source of amino acids, a mechanism employed 
by tumor cell lines to meet their increasing metabolic demands 
(31–33). Consistent with glutamine being an important metabolic 
substrate (34), a number of key enzymes and transporters involved 
in glutaminolysis (glutaminase, glutamate dehydrogenase, alpha 
ketoglutarate dehydrogenase, phosphoenolpyruvate carboxyki-
nase 2, and the dicarboxylate transporter) are upregulated at the 
protein level in hypoxia (Figure 5A). The ability of neutrophils to 
use an active protein uptake pathway to fuel their energetic require-
ments at sites of inflammation would represent an advantageous 
metabolic adaptation to the inflamed lung niche.
To definitively address whether neutrophils can use extracel-
lular proteins for anaplerosis, we fed ex vivo airspace neutrophils 
with 13C5 glutamine–labeled proteins and traced the presence of 
heavy carbons into their metabolic intermediaries. Label could be 
traced into TCA cycle metabolites including citrate, fumarate, and 
equivalent to those isolated 24 hours after LPS. Sixty-two newly syn-
thesized (labeled) proteins were identified by mass spectrometry, 
including abundant proteins involved in cytoskeletal regulation and 
metabolism (Figure 3A and Supplemental Table 5) as would be pre-
dicted from our initial proteomic screens (Figure 1, B and C). Impor-
tantly, we also identified labeling within inflammatory proteins such 
as complement C3 and integrins (Figure 3B) and granule proteins 
(Figure 3C) (27). De novo protein synthesis contributed substantially 
to the overall abundance of these granule proteins, with up to 10% 
heavy label incorporation. Coupled with the evidence of preserved 
intracellular granule proteins despite enhanced degranulation, these 
data are consistent with de novo synthesis of inflammatory medi-
ators, including granule proteins by tissue neutrophils, providing 
a mechanism by which hypoxic neutrophils would be predicted to 
drive a hyperinflammatory immune response.
Neutrophils scavenge extracellular proteins for fuel. Despite their 
well-recognized reliance on glycolysis for ATP production, we found 
that airway neutrophils are subject to marked hypoglycemia. Only 
very low levels of glucose were present in BAL supernatant (Supple-
mental Figure 4A) (28, 29). In order to more accurately determine 
the absolute concentration of glucose that cells within the airways 
are exposed to (without the diluting effect of the BAL), we also per-
formed LCMS analysis of airway surface liquid that was adsorbed 
onto filter cards directly from the upper airways. This confirmed 
low levels of glucose in the airways of both normoxic and hypoxic 
mice (Figure 4A). Although hypoxic neutrophils did upregulate the 
glucose transporter Glut 3 (Figure 4B), this did not translate to an 
increase in intracellular glucose-6-phosphate (Figure 4C), likely 
due to the low substrate availability. We therefore asked how airway 
neutrophils are able to support the observed synthetic function in 
Figure 3. Airspace neutrophils synthesize granule proteins. BAL neutrophils were cultured ex vivo with labeled amino acids (n = 4 over 2 experiments). 
Labeled proteins (identified by mass spectrometry, total number = 62) were assigned to a functional group as detailed in (A). Those involved in inflamma-
tion (B) and neutrophil granules (C) are detailed. Panels B and C represent individual values and mean ± SEM with labeling expressed as the percentage of 
the protein that demonstrates incorporation of heavy labeled amino acid(s). Raw data are detailed in Supplemental Table 5.
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malate (Figure 5, B–D, and Supplemental Figure 4, C–F), consistent 
with flux of protein-derived glutamine into central carbon metabo-
lism. We did not identify any evidence of reductive carboxylation, 
with no m+5 citrate (Supplemental Figure 4C) and no m+3 malate 
(Supplemental Figure 4D) identified. These experiments did not 
allow us to conclusively comment on TCA cycling, and though we 
did identify the presence of small amounts of m+2 citrate, we did 
not see labeling within oxaloacetate (data not shown). Neutrophils 
therefore have the capacity to use extracellular proteins as an ami-
no acid source for metabolic intermediaries.
Hypoxia and mTORC1 activity regulate neutrophil catabolism of 
scavenged extracellular proteins. To investigate the use of extracellu-
lar proteins by neutrophils, we used Texas red–labeled bovine serum 
albumin (BSA) to measure protein uptake and double-quenched 
Green–labeled (DQ-Green–labeled) BSA (which requires proteolyt-
ic cleavage to emit green fluorescence) to measure breakdown. We 
used human blood neutrophils in addition to murine BAL neutro-
phils to confirm that protein scavenging is of functional relevance in 
a broader range of neutrophil subsets. Incubation of healthy human 
peripheral blood neutrophils with Texas red BSA demonstrates 
rapid uptake with a significant increase in Texas red signal after a 
30-minute incubation (Figure 6A). Rapid proteolysis also occurs 
with a significant increase in the DQ-Green signal observed after 
90 minutes (Figure 6A). To confirm that the observed DQ-Green 
signal was a direct result of intracellular proteolysis, rather than 
extracellular proteolysis and uptake of unquenched fluorescent 
BSA, the DQ-Green BSA time course was repeated following a wash 
at 30 minutes to remove residual extracellular albumin. Consistent 
with intracellular breakdown of DQ-Green BSA, there was a signif-
icant increase in intracellular fluorescence over a 2-hour incubation 
period with fresh media (Figure 6B).
In order to delineate the mechanism by which neutrophils 
take up albumin, we used confocal microscopy to assess localiza-
tion of FITC-BSA and Texas red 70 kDa dextran, a substance pre-
dominantly taken up via macropinocytosis (35). Merged images 
revealed partial colocalization of the BSA signal with the 70 kDa 
dextran (Figure 6C), indicating that one route of albumin uptake 
is via macropinocytosis (36).
Figure 4. Hypoglycemic neutrophils scavenge extracellular proteins. (A) Glucose concentration of airway surface liquid (n = 4 over one experiment). (B) LFQ of 
glucose transporters GLUT1 and GLUT3, n = 3. (C) Intracellular abundance of glucose-6-phosphate measured by HPLC-MS (n = 8 over 2 experiments). (D) Intracel-
lular abundance of glutamate and glutamine (n = 8 over 2 experiments). (E) Glutamine concentration of airway surface liquid from normoxic and hypoxic mice 24 
hours after LPS (n = 4 over one experiment). LFQ of (F) albumin, (G) IgM, and (H) fibronectin in BAL neutrophils, n = 3. A and C–E used a Mann-Whitney test of 
significance. B and F–H used the unpaired 2-tailed t test of significance. All data are from normoxic and hypoxic mice 24 hours after nebulized LPS.
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We hypothesized that in neutrophils, nutrient availability may 
play a role in regulating protein uptake. In light of the glucose- 
deplete nature of the inflamed airway, we incubated LPS-treated 
human peripheral blood neutrophils in the presence or absence of 
glucose and compared normoxic (21% O2) with hypoxic (1% O2) 
culture. Comparing the signal from neutrophils incubated with 
Texas red BSA with those incubated with DQ-Green BSA identified 
an interesting distinction between conditions that favor uptake ver-
sus those that favor breakdown. In glucose-replete media, hypoxia 
enhances albumin uptake. This trend is preserved in glucose deple-
tion but is nonsignificant (Figure 6D). In both normoxia and hypox-
ia, the absence of glucose results in reduced uptake of albumin but 
this is significant only in hypoxia (Figure 6D). In contrast, hypoxia 
enhances albumin breakdown in both glucose-replete and -deplete 
conditions (Figure 6E), and glucose depletion does not limit albu-
min breakdown. This suggests that the increase in albumin catabo-
lism that is driven by hypoxia is sufficient to overcome any reduced 
substrate uptake due to glucose deprivation. This is illustrated by 
Figure 5. Glutamine from scavenged proteins fuels hypoxic neutrophils. (A) LFQ of proteins involved in glutaminolysis, n = 3, unpaired 2-tailed t test of 
significance. (B–D) Highly pure BAL neutrophils harvested 6 hours after nebulized LPS from hypoxic mice were cultured ex vivo for 18 hours in hypoxia (1%O2) in 
glucose-free media supplemented 13C5 glutamine–labeled (green) or unlabeled (white) HEK cell lysates. Metabolite abundance and labeling was measured by 
HPLC-MS (n = 4 over 2 experiments), Mann-Whitney test of significance. Diagram represents the glutaminolysis pathway with enzymes in yellow and metabolic 
intermediaries in green. GLS, glutaminase; GLUD1, glutamate dehydrogenase 1; OGDH, 2-oxoglutarate dehydrogenase; PCK2, phosphoenolpyruvate carboxykinase.
The Journal of Clinical Investigation R E S E A R C H  A R T I C L E
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mTORC1 activity and protein breakdown by neutrophils. Our pro-
teomic data confirmed that neutrophils express the key compo-
nents of mTORC1, mTORC2, and the Ragulator complex proteins 
LAMTOR1–3 required for translocation of mTORC to the lyso-
somal membrane (Supplemental Figure 5, A and B) (37). The basal 
activity of mTORC1 in human peripheral blood neutrophils was 
analyzed using the phosphorylation status of the downstream tar-
get S6 kinase (S6K). In unstimulated neutrophils, mTORC1 activ-
ity was low and LPS treatment resulted in a significant increase in 
phosphorylated S6K (Supplemental Figure 5C). Oxygen and glu-
cose availability dramatically altered the activity of mTORC1 in 
LPS-treated human peripheral blood neutrophils with suppression 
of mTORC1 activity by both hypoxia and glucose deprivation (Fig-
ure 6J), an effect replicated in vivo with diminished expression of 
phosphorylated S6K in airspace neutrophils isolated from hypoxic 
mice (Figure 6K). To investigate whether mTORC activity directly 
regulates catabolism of extracellular proteins, human peripher-
al blood neutrophils were incubated with the mTORC inhibitor 
Rapamycin or with the mTORC activator MHY1485 (38) prior to 
the addition of LPS and DQ-Green BSA. With mTORC inhibition, 
we observed a significant increase in proteolysis (as measured by 
DQ-Green fluorescence) and with mTORC activation, a signifi-
cant decrease (Figure 6L). Thus, mTORC activity inhibits break-
down of proteins in neutrophils, and mTORC suppression under 
oxygen- and glucose-deplete conditions relieves this inhibition.
Hypoxia upregulates lysosomal catabolism of extracellular pro-
tein by tissue neutrophils for anaplerosis. The lysosome is essential 
for cellular protein degradation. To investigate the importance of 
lysosomal trafficking for extracellular protein catabolism by neu-
trophils, we first verified the cellular localization of scavenged 
albumin. Using confocal microscopy, we observed colocalization 
of DQ-Green BSA with the lysosomal marker LAMP1 (Figure 7A). 
Thus, neutrophils have capacity to traffic proteins from the extra-
cellular environment to the lysosome. KEGG pathway analysis of 
those proteins upregulated by hypoxia at a proteomic level revealed 
enrichment for the lysosome pathway (fold enrichment 1.564, P = 
0.032), with more detailed analysis of known lysosomal proteins 
(39) confirming the majority of lysosomal pathway members to 
be upregulated by hypoxia (Figure 7B and Supplemental Table 4). 
In the hypoxic inflamed airway, neutrophils can upregulate both 
the lysosomal pathway (Figure 7B) and the enzymes required to 
metabolize the resultant free amino acids, such as glutamine (Fig-
ure 5A). The importance of the lysosome for protein catabolism 
is further supported by the observation that a lysosomal protease 
inhibitor E64 (32) (Figure 7C) and an inhibitor of lysosomal acid-
ification chloroquine (40) (Figure 7D) diminish the ability of neu-
trophils to breakdown DQ-Green BSA in vitro. Furthermore, lyso-
somal proteins accounted for 14% of newly synthesized proteins in 
the previous amino acid tracing experiments (Figure 3A), further 
highlighting the importance of this organelle in the inflammato-
ry neutrophil. Neutrophils therefore have the capacity to regulate 
uptake and degradation of extracellular proteins via the lysosome 
to provide amino acids required for the provision of metabolic 
intermediaries. Hypoxia and glucose deprivation positively regu-
late these processes via mTOR and the lysosome.
Hypoxia promotes a damaging hyperinflammatory neutrophil phe-
notype in vivo. In response to systemic hypoxia, we have observed 
the ratio of DQ-Green to Texas red fluorescence in each condition, 
which can be used as an indicator of the proteolytic activity of the 
cells. This showed that LPS-stimulated neutrophils incubated in 
hypoxia without glucose (conditions most closely resembling the 
hypoxic airway) had significantly higher proteolytic capacity than in 
any other condition (Figure 6F). This is consistent with the hypoth-
esis that in conditions of nutrient scarcity, neutrophils exploit their 
environment to scavenge alternative energy supplies in the form of 
protein, and that hypoxia positively regulates this process. In order 
to investigate the in vivo relevance of this observation, inflammato-
ry BAL neutrophils from normoxic and hypoxic mice were cultured 
ex vivo with Texas red BSA and DQ-Green BSA (with those from 
normoxic mice cultured in 21% oxygen and those from hypoxic 
mice cultured in 1% oxygen). In these ex vivo cells, hypoxia drives 
both increased protein uptake and degradation (Figure 6, G and 
H). Thus, transmigration into the alveolar space and/or exposure 
to the inflammatory milieu further augments neutrophil protein 
scavenging capacity. Measurement of cell culture supernatant fluo-
rescence confirmed that the enhanced DQ-Green signal in hypoxia 
did not represent enhanced extracellular DQ activation secondary 
to increased degranulation of neutrophil proteases (Figure 6I).
In tumor cells, the mammalian target of rapamycin (mTOR) 
and its associated complexes mTORC1 and mTORC2 are essen-
tial in integrating signals regarding nutrient availability. Down-
stream signaling then determines the cellular response to these 
signals in terms of transcription and translation of new proteins 
and in directing proliferation (32). Interestingly, data in fibroblasts 
showed that mTORC1 activity negatively regulated lysosomal 
degradation of proteins taken up from the environment (32). We 
speculated that there might also be an inverse correlation between 
Figure 6. Hypoxia promotes mTOR regulated neutrophil catabolism of 
extra-cellular albumin. Time course of human peripheral blood neutro-
phils incubated with (A) Texas red–labeled BSA or DQ-Green BSA for 150 
minutes (data expressed as % maximum signal) and (B) DQ-Green BSA for 
30 minutes followed by washing and then further incubation for 120 min-
utes. A and B were measured by flow cytometry (n = 3 over 2 experiments). 
(C) Confocal microscopy of human peripheral blood neutrophils incubated 
with FITC-BSA (green) and 70 kDa dextran (red) with DAPI nuclear staining 
in blue and red/green colocalization highlighted in yellow. Geometric mean 
fluorescence of LPS-treated human neutrophils incubated with (D) Texas 
red–labeled BSA (n = 6) or (E) DQ-Green BSA (n = 7 over 3 experiments) in 
normoxia or hypoxia (1% O2) in RPMI with or without glucose (11 mM). (F) 
Ratio of DQ-Green to Texas red signal demonstrating breakdown efficiency 
in the conditions described in D and E; n = 6 over 3 experiments. Geometric 
mean fluorescence of BAL neutrophils from normoxic or hypoxic mice 24 
hours after LPS incubated ex vivo in the corresponding oxygen tension 
with (G) Texas red BSA or (H) DQ-Green BSA (n = 4 over one experiment). 
(I) Fluorescence of cell culture supernatant from H. mTORC1 activity (pro-
portion of phosphorylated S6 kinase) in (J) LPS-treated human peripheral 
blood neutrophils cultured in normoxia or hypoxia (1% O2) with or without 
glucose (11 mM) (n = 7 over 4 experiments) and (K) murine BAL neutrophils 
isolated 24 hours after nebulized LPS (mice housed in normoxia or hypox-
ia); n = 8 over 2 experiments. Representative blots shown. (L) Geometric 
mean fluorescence of LPS-treated human neutrophils incubated with 
DQ-Green BSA and pretreated with MHY1485 (2 μM) or Rapamycin (50 
nM); n = 4 over 2 experiments. In A and B, data represent mean ± SEM. In 
D–J, data represent individual values and mean ± SEM. A, B, D–F, J, and L 
were analyzed by ordinary 1-way ANOVA with multiple comparisons. G–I 
and K used the Mann-Whitney test of significance.
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to ongoing inflammatory mediator production (Figure 3) and, in 
hypoxia, increased granule protease release into the lung is asso-
ciated with increased lung injury, culminating in a vicious cycle of 
persistent inflammation. To confirm the physiological relevance 
of lysosomal protein trafficking for inflammation outcomes, we 
explored the consequence of in vivo administration of chloroquine 
in the LPS lung injury model. Administration of i.p. chloroquine 
(43, 44) resulted in a partial rescue of the hypothermia observed 
following LPS challenge (Figure 8I), without a reduction in neu-
trophil numbers (Figure 8J). When BAL neutrophils were cultured 
ex vivo with DQ-Green albumin for 2 hours, as predicted from 
our in vitro treatment of human blood neutrophils, there was an 
associated reduction in DQ-Green fluorescence in airway neutro-
phils harvested from the chloroquine-treated mice, indicating that 
i.p. chloroquine is sufficient to reduce the lysosomal breakdown 
capacity of neutrophils recruited to the airways (Figure 8K). More-
over, analysis of the BAL supernatant showed a suppression of neu-
trophil granule protease production with a reduction in elastase 
activity in the airways of chloroquine-treated mice (Figure 8L). 
Thus, systemic chloroquine treatment in mice leads to reduced neu-
trophil lysosomal activity and is associated with diminished release 
of neutrophil granule proteins in the airways. Further work will be 
required to delineate whether the observed effects of chloroquine 
relate directly to lysosomal inhibition and whether specific target-
ing of the lysosome can drive resolution of neutrophil-mediated 
inflammatory lung disease.
Discussion
The factors that tip the balance of neutrophil phenotype from 
functional immunity to pathological inflammation remain poorly 
that neutrophils restructure their proteome and enhance extracellu-
lar protein scavenging. This is associated with increased inflamma-
tion within the tissues. To determine the biological consequences 
of these proteomic adaptations, we explored the physiological out-
comes of exposing mice to systemic hypoxia in the context of acute 
lung injury. Concurrent exposure of mice to LPS and hypoxia result-
ed in profound hypothermia over the first 24 hours (Figure 8A), a 
response replicated in the setting of bacterial pneumonia (6) and in 
keeping with a more severe inflammatory response. In keeping with 
hypoxic upregulation of inflammatory receptors and degranulation 
(Figure 2, A–E), analysis of the BAL fluid supernatant revealed an 
increase in lung injury demonstrated by significantly more capil-
lary leak of albumin (Figure 8B) and IgM (Figure 8C) in hypoxia. 
The very high levels of intracellular albumin and IgM observed in 
hypoxia (Figure 4, F and G) are therefore likely to be a consequence 
of both increased substrate availability and increased uptake. While 
we did demonstrate increased capacity for protein uptake in hypox-
ic BAL neutrophils (Figure 6G), this relatively modest increase 
is unlikely to be sufficient to overcome the nearly 3-fold increase 
in BAL albumin concentration in the lungs of hypoxic mice. The 
excess lung damage was independent of neutrophil number, with 
preserved BAL (Figure 8D) and interstitial (Figure 8E) neutrophil 
counts, despite lower circulating neutrophil numbers (Figure 8F) in 
hypoxia. Evidence of increased sickness and more significant lung 
injury in response to hypoxia, together with in vivo evidence of 
activated neutrophil surface phenotypes confirm important bio-
logical consequences of the observed proteomic changes (Fig-
ure 8, G and H) (41, 42). In hypoxia, increased protein leak pro-
vides abundant substrate for the upregulated processes of protein 
scavenging and catabolism. De novo protein synthesis contributes 
Figure 7. Lysosomal catabolism of extracellular protein provides substrate for de 
novo protein synthesis. (A) Confocal microscopy of human peripheral blood neutro-
phils incubated with DQ-Green BSA (green) and subsequently fixed and permeabilized 
and stained for the lysosomal marker LAMP-1 (red) with DAPI nuclear staining in blue 
and red/green colocalization highlighted in yellow. (B) Volcano plot comparing the pro-
teomes of hypoxic and normoxic neutrophils (as in Figure 1H) with lysosomal pathway 
members which are significantly up- (green) and downregulated (red) highlighted. 
Geometric mean fluorescence of LPS-treated human neutrophils incubated with 
DQ-Green BSA and pretreated with (C) protease inhibitor E64 or (D) the inhibitor of 
lysosomal acidification chloroquine; n = 7 over 4 experiments, Wilcoxon 2-tailed test 
of statistical significance. Panels C and D represent individual values and mean ± SEM.
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
1 1J Clin Invest. 2021;131(10):e134073  https://doi.org/10.1172/JCI134073
The Journal of Clinical Investigation R E S E A R C H  A R T I C L E
J Clin Invest. 2021;131(10):e134073  https://doi.org/10.1172/JCI1340731 2
by which early neutrophil mediated damage and protein leak would 
provide substrate to fuel this continued inflammatory response.
The observation that, in hypoxia, high concentrations of gran-
ule proteases in the supernatants are not accompanied by reduced 
intracellular levels of these proteins led us to investigate whether 
tissue neutrophils continue to synthesize granule contents. Incor-
poration of labeled amino acids into newly synthesized granule 
proteins confirmed their ongoing production by tissue neutro-
phils. We also provide direct evidence that neutrophils can release 
amino acids from scavenged proteins, fueling central carbon 
metabolism. These observations, in conjunction with our findings 
of increased levels of granule proteins in hypoxia, where protein 
scavenging is also increased, raise the possibility that amino acids 
from scavenged proteins may also provide substrate for protein 
synthesis. The enhanced capacity for protein translation observed 
in hypoxic neutrophils, coupled with increased protein substrate 
availability, would support this concept. This hypothesis is further 
supported by the evidence that in vivo inhibition of lysosomal pro-
tein catabolism led to reduced neutrophil elastase production by 
airway neutrophils. Further work is required to confirm whether 
amino acids from scavenged proteins can be incorporated in new-
ly synthesized proteins by neutrophils in the inflammatory niche.
There are clear parallels to be drawn between the harsh oxy-
gen- and glucose-limited environment of the inflamed lung and the 
tumor microenvironment (47). Macropinocytosis of protein has been 
shown to be an important metabolic adaptation by tumor cells to 
metabolic stress (32, 33). In human blood neutrophils, the observed 
colocalization of FITC-BSA with dextran and LAMP1 also highlights 
a role for macropinocytosis in the delivery of extracellular proteins to 
the neutrophil lysosome. It is unlikely that macropinocytosis reflects 
the only mechanism of protein uptake given the partial correlation 
of BSA with dextran and the capacity of neutrophils, as professional 
phagocytes, to ingest particles by a number of alternative routes.
The importance of extracellular protein uptake to the metabol-
ic adaptations of neutrophils within the inflammatory niche was 
explored in a series of labeled protein tracing experiments. Our data 
provide direct evidence that immune cells are able to derive amino 
acids from proteins for central carbon metabolism. This substrate 
utilization is promoted by hypoxic upregulation of the lysosomal 
compartment and concurrent suppression of mTORC1 activity, aug-
mented by glucose deprivation, allowing unfettered catabolism of 
proteins in the lysosome. Increased expression of enzymes involved 
in glutaminolysis further supports metabolism of the resulting free 
amino acid pool in hypoxia facilitating anaplerosis. Neutrophils use 
gluconeogenesis to generate glycogen stores with glycogen cycling 
retaining energy production when extracellular glucose is limited 
(34). In this work, we propose that glutamine derived from scav-
enged proteins feeds into this gluconeogenic response, generating 
ATP. It is interesting to speculate whether substrate-level phosphor-
ylation at the level of succinate coA ligase could also be contribut-
ing to ATP production in this context. The inflammatory capability 
of neutrophils is not therefore limited to releasing proteases from 
preformed granules, but is dynamic and adapted to the inflamma-
tory niche. Understanding the factors that regulate the capacity 
of neutrophils to synthesize and release granule proteins will be 
a significant focus moving forward. Direct evidence of protein- 
derived amino acid incorporation into newly synthesized proteins 
understood. As a consequence, designing therapies for the many 
pathologies that are known to be mediated by neutrophilic inflam-
mation remains a major challenge. Study of the proteome of the 
inflammatory neutrophil provides insights into the importance 
of biosynthesis for neutrophil function, with neutrophils demon-
strating enrichment for the ribosome and RNA transport as well 
as inflammatory pathways. Comparison of normoxic and hypox-
ic neutrophil proteomes demonstrated that neutrophils have the 
capacity to restructure their proteomes to adapt to physiological 
stressors and regulate these important biosynthetic functions. 
Exploring the biological consequence of these metabolic adapta-
tions provided insights into the mechanisms by which neutrophils 
sustain their effector functions in the tissues.
Protein-rich exudates are pathognomonic of acute lung injury. 
In this work, we observed that protein leak is not only a marker of 
lung damage but also has the capacity to drive further inflamma-
tion, with the finding that airspace neutrophils can take up extra-
cellular proteins. We showed for the first time that neutrophils 
not only scavenge proteins from their environment but use these 
ingested proteins to contribute amino acids to maintain central 
carbon metabolism. Moreover, this response is quick, with lyso-
somal breakdown of extracellular albumin occurring within 90 
minutes and evidence of contribution to metabolite synthesis at 18 
hours. This is consequently of biological importance given the pre-
dicted lifespan of tissue neutrophils following recruitment during 
an acute inflammatory response (45, 46), which is further extend-
ed by the presence of both tissue and systemic hypoxia (1, 7).
The hypoxic inflamed lung represents an optimal niche to 
increase neutrophil capacity for protein consumption, providing 
increased access to extracellular albumin and IgM, suppression of 
mTORC activity, and promotion of lysosomal catabolism. We pro-
pose that initial hypoxic induction of formylated peptide, TNF-α, 
and GM-CSF inflammatory receptors further provides a mechanism 
Figure 8. Hypoxia promotes a hyperinflammatory neutrophil phenotype 
abrogated by lysosomal inhibition. (A) Body temperature of mice housed 
in hypoxia (10% O2) or normoxia for 24 hours after nebulized LPS and 
untreated mice housed in hypoxia; n = 4 over 2 experiments, analyzed by 
2-way ANOVA with Tukey’s multiple comparisons test. **P < 0.01, ****P <  
0.0001. BAL supernatant from normoxic and hypoxic mice 24 hours after 
LPS was analyzed for (B) albumin (n = 9 over 2 experiments) and (C) IgM (n 
= 5 over one experiment) by ELISA. (D) BAL neutrophil counts from normox-
ic or hypoxic mice following nebulized LPS; n = 4 (one experiment) at 2 hour 
and 48 hour time points, or n = 8 (2 experiments) at 6 hour and 24 hour 
time points. Significance analyzed by multiple t tests (corrected for multi-
ple comparisons using Bonferroni method). (E) Lung neutrophil counts (n = 
6 over 2 experiments) and (F) blood neutrophil counts (n = 9 over 3 exper-
iments) of mice housed in normoxia or hypoxia for 24 hours following LPS 
nebulization. BAL neutrophils isolated 24 hours after nebulized LPS from 
normoxic or hypoxic mice were analyzed by flow cytometry for expression of 
(G) CD11b and (H) CD62L (n = 6–7 over 2 experiments). (I) Body temperatures 
and (J) BAL neutrophil counts from mice 24 hours after LPS nebulization, 
treated with i.p. chloroquine or i.p. PBS at 4 hours and housed in normoxia 
or hypoxia. (K) BAL neutrophils incubated ex vivo with DQ-Green BSA and 
analyzed by flow cytometry and (L) elastase activity in BAL supernatant 
from the same mice. I, K, and L: n = 9–10 over 3 experiments. J: n = 6–7 over 
2 experiments. J–L used unpaired t test. I used Mann-Whitney test of sig-
nificance (data not normally distributed). In A and D, data represent mean ± 
SEM. Data in B, C, and E–L represent individual values and mean ± SEM.
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0.9% NaCl and BAL fluid kept on ice until further processing. Cell 
counts were carried out using a hemocytometer and purity assessed 
by morphology on cytospin.
A discontinuous Percoll gradient (78%, 69%, and 52% Percoll) 
was used to purify BAL neutrophils for RNA, protein, and metabolite 
assays. Residual red blood cells were lysed by hypotonic saline lysis. 
Purity was assessed by morphology and flow cytometry with neutro-
phil purity greater than 98%.
Murine lung digest
Following the BAL protocol described above, the right ventricle was 
cannulated, and the circulation flushed with 10 mL of ice-cold PBS to 
minimize circulating leucocytes within the lung vasculature prior to 
lung harvest. The lung tissue was mechanically dissociated using scis-
sors prior to enzymatic digestion with collagenase V (0.8 mg/mL, Sig-
ma-Aldrich), Collagenase D (0.625 mg/mL, Roche), Dispase (1 mg/mL, 
Gibco) and DNase (30 μg/mL, Roche) made up in RPMI. The digest was 
then passed through a 100 μm filter, washed with PBS and red cell lysis 
performed (Sigma-Aldrich) prior to resuspension in FACS buffer (PBS 
with 5% BSA and 2 mM EDTA). The cell suspension was passed through 
a 40 μm filter, counted using a NucleoCounter automatic cell counter 
(Eppendorf) and processed for flow cytometry analysis.
Cell culture
For all experiments, murine neutrophils were cultured at a density of 1 × 
106/mL and human neutrophils at a density of 5 × 106/mL. Media were 
supplemented with 1% penicillin streptomycin (Gibco) and 10% dia-
lyzed FCS (Gibco) unless otherwise stated. Neutrophils were cultured in 
RPMI 1640 media with 2 mM glutamine (Gibco). The glucose-replete 
media had 11 mM d-glucose. Standard cell culture was carried out in 
a Thermo Fisher Scientific Heraeus BB15 CO2 incubator. For hypoxic 
cell culture, conditions were as above but cells were cultured in a Ruskin 
hypoxic work station (Ruskin) with an O2 of 1% and CO2 of 5%. Humid-
ity in the hypoxic work station was maintained at 70%.
HEK cell lysates were used as a substrate to analyze the downstream 
use of scavenged proteins. HEK 293 cells were a gift from Alex Von 
Kriegsheim (Institute of Genetics and Molecular Medicine, University 
of Edinburgh, Edinburgh, United Kingdom). Control cells were cultured 
in glucose-replete DMEM (Gibco) with 10% dialyzed FCS, 1% penicillin 
streptomycin, and 2 mM l-glutamine. For glutamine labeling experi-
ments, standard l-glutamine was substituted with 13C5-labeled glutamine 
(Cambridge Isotopes) for 72 hours prior to being harvested and lysed.
Acetone precipitation of HEK cell proteins
Cells were harvested and washed 3 times with ice-cold PBS. The cell 
pellet was then lysed by hypotonic lysis in 4 mL of sterile water prior 
to sonication and acetone precipitation, with supernatants (containing 
small molecules such as metabolites and free amino acids) discarded. 
Samples were centrifuged at 15,000g for 10 minutes to remove insol-
uble protein material and supernatants used for downstream culture. 
Protein content was measured by Pierce BCA assay (Thermo Fisher 
Scientific) and normalized between labeled and unlabeled samples.
Ex vivo culture of BAL neutrophils with glutamine-labeled HEK cell 
proteins
BAL neutrophils were isolated and purified by Percoll gradient as 
detailed above. Following purification, neutrophils were resuspended 
has proved technically challenging but remains an area of active 
investigation. It is also interesting to speculate whether microen-
vironmental factors, including hypoxia and metabolic stress may 
shape the transcriptome of the neutrophil, determining the program 
of protein synthesis, and whether the mechanism of release of these 
newly synthesized proteins is by further rounds of degranulation 
or involves alternative routes of exocytosis. This work has focused 
on the breakdown of extracellular proteins but it is important to 
acknowledge that the closely related process of autophagy, whereby 
cells recycle intracellular proteins, may also contribute to the amino 
acid pool in the neutrophil. In future work, it will be important to 
consider how the processes of transmigration and activation them-
selves alter the neutrophil proteome.
Given the frequency with which other inflamed tissues (48), 
including the bowel (49) and joint (50), are found to be hypoxic, 
the pathways identified here are likely to be relevant more broadly 
in the regulation of neutrophilic inflammation. These data contrib-
ute to our understanding of the mechanisms by which neutrophils 
sense and adapt to local microenvironmental stresses, characteris-
tic of the inflammatory niche and, as such, provide new strategies 
for the treatment of neutrophil-mediated inflammatory disease.
Methods
Isolation and culture of human peripheral blood neutrophils
Human peripheral blood neutrophils were isolated from sodium citrate 
anticoagulated blood by dextran sedimentation and discontinuous 
Percoll as previously described (51). Purity was assessed by morpholo-
gy on cytocentrifuge slides.
Murine LPS-induced acute lung injury
Mice were treated with LPS from Pseudomonas aeruginosa 10 (1 mg/mL, 
Sigma Aldrich) for 10 minutes using oxygen driven nebulization into 
a custom-built sealed system to generate a uniform and reproducible 
acute lung injury (7, 52). Following LPS treatment, animals were housed 
in either normal room air or in hypoxia. Animals were culled using an 
overdose of i.p. anesthetic at the appropriate time point (2–48 hours 
after nebulization) and tissues harvested.
Exposure to hypoxia
Mice were exposed to hypoxia (10% inspired O2) in an InVivo Hypoxic 
Cabinet System (Coy Labs) with excess CO2 scavenged using Sofnolime 
soda lime chips (Molecular Products) with color indicator. In models of 
acute hypoxia, LPS-stimulated, or naive mice were housed in hypoxia 
for 2 to 48 hours prior to tissue harvest.
Intraperitoneal chloroquine administration
Following administration of nebulized LPS, as described above, mice 
were housed in hypoxia or normoxia and at 4 hours were treated with i.p. 
chloroquine diphosphate (Sigma-Aldrich) at a dose of 50 mg/kg diluted in 
PBS. Control mice were given i.p. PBS alone. Following chloroquine or PBS 
injection, animals were housed as before in either normoxia or hypoxia 
until being culled by overdose of i.p. anesthetic 24 hours after LPS.
Murine neutrophil isolation
BAL neutrophils. The trachea was cannulated using a 24G cannula, 
which was tied in place. The lungs were washed with 4 mL ice cold 
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and raw data processed using MaxQuant software (53). Subsequent 
statistical analysis and figure generation was carried out using Per-
seus software (17), Microsoft Excel, and GraphPad Prism. The mass 
spectrometry proteomics data have been deposited to the Proteom-
eXchange Consortium via the PRIDE (54) partner repository with the 
data set identifier PXD013672.
Neutrophil protein lysates
Isolated neutrophils were washed twice with cold PBS following cul-
ture or purification. Cells were pelleted by centrifugation at 300g for 
5 minutes and the supernatant removed. The pellet was resuspended 
in Laemmli buffer with PMSF, phosphatase inhibitors, and protease 
inhibitors (100 μL Laemmli buffer per 1 million murine or 10 million 
human neutrophils). An equal volume of 2 times SDS lysis buffer was 
added and mixed by pipetting. The sample was then boiled for 5 min-
utes prior to storage at –80°C until use.
Immunoblot for protein expression
Neutrophil protein lysates were analyzed for protein expression by 
Western blot. Proteins were separated by SDS-PAGE (8%, 10%, or 
12% gels depending on protein size) using the BioRad mini-protean 
system prior to wet transfer onto PVDF membrane (Merck Millipore). 
Membranes were blocked using 5% skimmed milk powder for a min-
imum of 2 hours. Primary antibodies were from Cell Signaling Tech-
nology (p38 9212, P70 S6 kinase 2708, phospho-p70 S6 kinase 9234, 
HRP-linked anti-rat immunoglobulin 7077, HRP linked anti-mouse 
immunoglobulin 7076), Abcam (elastase Ab205670, MMP9 Ab58803, 
MPO Ab 188211), and Dako (HRP linked anti-rabbit immunoglobulin, 
p044801) and were made up in 5% skimmed milk in 1× TBS-Tween 
(TBST, 0.05% Tween). Membranes were incubated at 4°C overnight on 
a rolling platform. Membranes underwent 3 washes in 1× TBST prior 
to incubation with the appropriate horseradish peroxidase–conjugated 
(HRP-conjugated) secondary antibody for 1 hour at room temperature. 
The membrane was washed as above prior to developing in enhanced 
chemiluminescent (ECL) detection reagent (GE Healthcare). Chemi-
luminescence was assessed using a Licor Odyssey Fc machine and 
quantified using ImageStudioLite software. Protein quantification was 
normalized to a loading control as follows: the membrane was stripped 
using Restore Western Blot stripping buffer (Thermo Fisher Scientific), 
washed with dH2O, and then reprobed for the loading control protein 
(or, for the nonphosphorylated form of the protein of interest where 
appropriate) with primary and secondary antibodies as above. The 
membrane was then developed and protein quantified as above.
Neutrophil RNA extraction and TaqMan analysis of gene expression
Percoll purified neutrophils were used to generate mRNA samples 
using the mirVana miRNA isolation kit (Invitrogen) as per manufacturer 
instructions followed by DNase treatment using the Invitrogen TURBO 
DNA free kit. The quantity and purity of the RNA were assessed using 
a Nanodrop 100 spectrophotometer. cDNA was generated using AMV 
reverse transcriptase and random primers (Promega) and samples were 
run on a Techne Thermal cycler as follows: 23°C for 5 minutes, 42°C for 
2 hours, 99°C for 2 minutes. Samples were stored at –20°C until use.
Gene expression was analyzed using predesigned qPCR prim-
er/probe assays from Integrated DNA Technologies (IDT) (Elane 
Mm.PT.58.6682392.gs, MMP9 Mm.PT.58.10100097, and MPO 
Mm.PT.58.5251395) and Prime Time Gene Expression Mastermix 
in glucose- and glutamine-free DMEM (Gibco) supplemented with 10% 
FCS and 400 μg/mL HEK cell protein isolated by acetone precipitation 
as above. Neutrophils were cultured at a density of 1 × 106/mL for 18 
hours in hypoxia. Following this period of culture, cells were washed 3 
times with sterile 0.9% NaCl prior to methanol lysis as detailed below.
HPLC-MS analysis of metabolites
Highly pure BAL neutrophils were analyzed for intracellular metabolite 
abundance either immediately following isolation or following culture 
with labeled HEK lysates. Following Percoll purification as described, 
cells were washed in ice-cold 0.9% NaCl prior to resuspension in 80% 
Methanol. Following centrifugation at 20,000g for 10 minutes at 4°C, 
pellets were retained and protein content measured by Pierce BCA 
assay (Thermo Fisher Scientific). Samples were analyzed at the VIB 
Center for Cancer Biology in Leuven using a Dionex UltiMate 3000 
LC System (Thermo Fisher Scientific) coupled to a Q Exactive Orbitrap 
mass spectrometer (Thermo Fisher Scientific) operated in negative 
mode. Data collection was performed using Xcalibur software (Ther-
mo Fisher Scientific). All data values were subsequently corrected for 
protein content based on the BCA assay.
Airway surface liquid was analyzed by insertion of custom made 
filter cards (Hunt Developments) into the upper airway of mice prior 
to BAL. Metabolites were subsequently eluted from the filter cards in 
200 μL of 40:40:20 methanol/acetonitrile/water. Following extraction, 
samples were stored at –80°C. Relative metabolite abundance was 
determined using ion-pairing reverse phase high performance liquid 
chromatography (RP-HPLC) or hydrophilic interaction liquid chroma-
tography coupled to a Q-Exactive Orbitrap Mass Spectrometer. Data 
were analyzed in a targeted manner using Xcalibur (Thermo Fisher 
Scientific) against an in-house compound library to integrate the area 
under the curve at the expected retention time and the average of 2 
replicates subjected to analysis. In order to extrapolate absolute values 
for airway glucose and glutamine, a standard curve was generated. The 
filter cards from the in vivo experiments were weighed to ascertain the 
mean volume of airway surface fluid that had been adsorbed onto the 
card (6.4 μL). An equivalent volume of either glucose or glutamine was 
applied to filter cards at varying concentrations and these samples were 
eluted and run in parallel with the experimental samples.
Sample preparation for proteomic analysis
Percoll purified BAL neutrophils were lysed in SDS lysis buffer with 
tris(2-carboxyethyl)phosphine at a 10 mM working concentration and 
boiled for 5 minutes. Samples underwent 15 minutes of sonication 
then incubation with benzonase for 15 minutes at 37°C. Protein con-
centration was estimated using the EZQ protein quantitation kit (Invi-
trogen). Following quantification, iodoacetamide (IAA) was added at 
a working concentration of 20 mM and lysates incubated for 1 hour 
at room temperature. In-solution digestion was carried out using SP3 
beads and LysC (overnight incubation at 37°C) at a concentration of 1 
μg LysC (Promega) per 100 μg protein followed by trypsin (Promega) 
digestion, also at 1 μg enzyme per 100 μg protein overnight at 37°C. 
Peptides were eluted using acetonitrile (ACN) and quantified using a 
3-(4-carboxybenzoyl)quinoline-2-carboxaldehyde (CBQCA) protein 
quantitation kit (Molecular Probes). Samples were diluted to a con-
centration of 1 μg/15 μL with 5% formic acid and 1 μg peptide was sub-
mitted for fractionation. Samples were fractionated using strong anion 
exchange chromatography, analyzed in an LTQ-Orbitrap Velos MS, 
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Triton X-100. The cells were washed again in PBS before staining with 
a deep-red cell mask (1 μg/mL, Invitrogen). For LAMP1 colocalization, 
cells were fixed using cytofix/cytoperm (BD Biosciences) and stained 
(LAMP1, Abcam mouse monoclonal) in 1× Perm/Wash buffer (con-
taining FCS and saponin). Alexa Fluor 647–conjugated goat anti-mouse 
secondary antibody (Abcam) was used for detection, with pellets resus-
pended in ProLong Gold liquid mountant with DAPI for nuclear stain-
ing (Invitrogen). Confocal images were acquired using a Leica SP5 con-
focal laser scanning microscope with Leica Application Suite software.
Statistics
Graphs were created in GraphPad Prism 7, Microsoft Excel, or Per-
seus (17). KEGG pathway enrichment analysis (19) was carried out 
using online DAVID bioinformatics tools. A P value less than 0.05 was 
considered significant.
Study approval. C57BL/6JOlA mice were purchased from Envigo. 
Male mice aged 8-10 weeks were used in all experiments. All mouse 
experiments were conducted in accordance with the Home Office 
Animals (Scientific Procedures) Act of 1986 under a Home Office 
Project License (PPL 70/8364) with local ethics approval.
Human peripheral venous blood was taken from healthy volun-
teers with written informed consent as approved by the University of 
Edinburgh Centre for Inflammation Research Blood Resource Man-
agement Committee (AMREC 15-HV-013). Volunteers were 61% 
female and aged 21–40 years (55% in the 21–30 years age bracket and 
65% in the 31–40 years age bracket).
The mass spectrometry proteomics data have been deposited to 
the ProteomeXchange Consortium via the PRIDE (54) partner reposi-
tory with the data set identifier PXD013672.
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Mm.PT.39a.22214843.g). Assays were run on a 7900HT Fast real-time 
PCR system (Applied Biosystems). Data was analyzed using SDS 2.0 
software (Thermo Fisher Scientific).
Analysis of BAL supernatant
The first 0.8 mL aliquot of BAL fluid was used to analyze the activity or 
quantity of a number of proteins and metabolites within the BAL fluid. 
The freshly isolated aliquot was kept on ice and centrifuged at 350g for 
10 minutes at 4°C to pellet the BAL leukocytes and erythrocytes pres-
ent in the aliquot. The supernatant was removed into a fresh tube, flash 
frozen on dry ice, and stored at –80°C until use. In all assays, commer-
cial kits were used as per the manufacturer protocol (IgM ELISA Abcam 
Ab133047, Albumin ELISA Abcam Ab108792, EnzCheck Elastase 
Activity Assay kit Invitrogen E12056, EnzCheck MPO Activity Assay 
kit Invitrogen E33856, MMP9 ELISA Bio-Techne MMPT90) and the 
optimal dilution of samples was preoptimized for each different analyte.
Analysis of murine neutrophils by flow cytometry
Blood (300–500 μL) was collected into 30 μL EDTA and underwent 
red cell lysis as described above. Cells were counted using a hemo-
cytometer and 2 × 105 cells were stained for flow cytometric analysis. 
Whole BAL was counted by hemocytometer and resuspended at a 
density of 1 × 106 cells/mL. An aliquot of 2 × 105 cells was then stained 
for analysis. Following digest as described above, 2 × 105 cells were 
stained and analyzed by flow cytometry.
Murine flow cytometry staining protocol
A viability assay was conducted for lung digest samples only. Samples 
were first resuspended in Live/Dead fixable Aqua stain (Invitrogen) as 
per manufacturer’s protocol. For all tissue types, samples were blocked 
in 25 μL PBS with 10% mouse serum and 1% Fc Block (Biolegend) for 
15 minutes on ice. The antibody master mix was made up in PBS and 
50 μL master mix was added to each sample. Cells were stained for 
30 minutes on ice in the dark prior to being washed 3 times in FACS 
buffer and either being fixed in 4% PFA for 15 minutes at room tem-
perature or analyzed immediately on a BD LSR Fortessa cell analyzer. 
For all flow cytometry experiments, data were acquired using FACS 
Diva software and analyzed using FlowJo software (version 10.1). Flow 
cytometry antibodies are detailed in Supplemental Table 6.
Dextran and albumin uptake assays
Neutrophils were preincubated in normoxia or hypoxia, in glucose- 
deplete or -replete media for 2 hours prior to the addition of Tex-
as red–labeled 70 kDa dextran (Invitrogen), FITC, or DQ-Green–
labeled BSA (Invitrogen) with or without LPS (100 ng/mL). E64 (2 
μM, Sigma-Aldrich), chloroquine (10 μM, Sigma-Aldrich), rapamycin 
(50 nM, Sigma-Aldrich), or the activator of mTOR MHY1485 (2 μM, 
Merck Chemicals) were added for 1 hour prior to fluorescent albumin. 
Uptake was quantified by flow cytometry and localization assessed by 
confocal microscopy.
Confocal microscopy
Confocal microscopy was used to delineate the intracellular location 
of the fluorescently labeled compounds described above. Neutrophils 
were washed and fixed in 4% PFA prior to permeabilization with 0.1% 
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